Scope
The Journal of Opioid Management (JOM) is designed to meet the challenge faced by medical professionals as they prescribe opioids. Coverage spans basic science, pre-clinical, clinical, abuse, addiction, public health, regulatory, legal, compliance and drug testing, titration, rotation, and the plethora of new clincal practice guidelines and stewardship programs designed to maximize patient care while reducing risk to the patient and public.
Journal of Opioid Management publishes original research articles, clinical reports, brief communications, articles related to new ideas or innovations, letters to the editor, editorials, invited book reviews, and meeting announcements.
Journal of Opioid Management fills what's been called "a dangerous gap" in medical literature at a time when the Federal spotlight has been switched on to the rising problem of abuse and addiction tied to these powerful painkillers. The Journal also addresses the issues of mis-use and under use.
Detailed article types:
Original Articles: Reports of original clinical or basic science data pertaining to prevalence, causes, mechanisms, diagnosis, course, treatment, and prevention, including systematic reviews and meta-analysis that represent a new contribution to the field.
Basic Science Investigations: Original articles presenting novel findings in opioid pharmacology, neurobiology, and molecular mechanisms underlying opioid-induced analgesia, tolerance, and addiction. These studies elucidate the cellular and molecular targets of opioids, neuroadaptive changes in the brain, and potential therapeutic targets for mitigating opioid-related adverse effects.
Pharmacological Interventions: Original articles focusing on the efficacy, safety, and novel approaches of pharmacological interventions in opioid management. This includes clinical trials, observational studies, and meta-analyses evaluating the effectiveness of different medications, dosage regimens, and combination therapies in opioid use disorder treatment.
Clinical Reports: Case reports presenting new or novel clinical information.
Telemedicine Case Studies: Clinical reports documenting the utilization and outcomes of telemedicine in opioid management. These case studies highlight the implementation of telehealth technologies, such as virtual consultations, remote monitoring, and digital interventions, in providing care for patients with opioid use disorder.
Ideas and Innovations: Short communications related to novel ideas, techniques, methods of assessment, etc.
Digital Health Innovations: Short communications showcasing innovative digital health solutions and technologies designed to improve opioid management and patient outcomes. This includes descriptions of mobile applications, wearable devices, artificial intelligence algorithms, and other digital tools aimed at enhancing opioid prescribing practices, monitoring adherence, and preventing opioid misuse.
Brief Communications: Preliminary or limited results (less than 1500 words, up to 3 figures or tables) of original research pertaining to prevalence, causes, mechanisms, diagnosis, course, treatment, and prevention.
Health Equity Briefs: Brief communications reporting preliminary findings and analyses on disparities in opioid use disorder prevalence, access to treatment, and health outcomes among diverse populations. These briefs address social determinants of health, cultural factors, and structural barriers influencing opioid-related disparities and propose strategies for promoting health equity in opioid management.
Clinical Trial Protocols: Detailed plans outlining the design, methodology, and objectives of clinical trials investigating interventions related to opioid management.
Intervention Trial Protocols Description: Detailed protocols outlining the design, methodology, and implementation of clinical trials evaluating novel interventions for opioid use disorder treatment and prevention. These protocols provide comprehensive descriptions of study aims, participant eligibility criteria, intervention protocols, outcome measures, and statistical analyses plans, ensuring transparency and reproducibility in clinical research.
Letters to the Editor: Comments in the form of letters that express differences of opinion or supporting views of recently published JOM content.
Patient Perspectives: Letters from patients or patient advocates sharing personal experiences, perspectives, and opinions on opioid management strategies, treatment approaches, and healthcare policies. These letters provide valuable insights into the lived experiences of individuals affected by opioid use disorder and contribute to a patient-centered dialogue within the journal. Letters should be unidentified. If submitted by a patient's doctor, a brief clinical analysis would be helpful.
Editorials: Brief substantiated commentaries (less than 1000 words) on subjects of interest to the JOM readership. Editorials should be narrative in form.
Policy Insights: Editorials offering concise analyses and reflections on policy developments, legislative changes, and regulatory initiatives impacting opioid management practices and public health efforts. These commentaries provide critical perspectives on policy implications, advocacy opportunities, and evidence-based recommendations to inform decision-makers and stakeholders in the field.
Legal, Clinical, and Regulatory Insights: Articles providing concise analyses and commentaries on legal developments, clinical prescribing, and regulatory initiatives shaping opioid management practices at the state and federal levels. These editorials explore the intersection of legal, clinical, and regulatory frameworks, addressing key issues such as opioid prescribing guidelines, drug scheduling, litigation trends, and policy implications for healthcare providers and patients.
If you have a manuscript that does not fit these categories, please send the abstract to us at jom@pnpco.com and we will present it to the editorial team for a quick answer.
To submit a manuscript, please go to https://www.editorialmanager.com/JOM/default.aspx . Click on "New users should register for a new account". After you register you will be able to click on a link to submit a manuscript, this will forward you to a page with instructions.
Editor-in-Chief: Paul A. Sloan, MD
Editorial Office:
Journal of Opioid Management
470 Boston Post Road
Weston, MA 02493
Phone (781) 899 - 2702
Fax (781) 899 - 4900
Email: jom@pnpco.com
Office Hours:
Monday through Friday 8:30 am - 5 pm (EST)
Manuscripts submitted for consideration must not have been previously published (except as an abstract), and must not be under consideration for publication elsewhere.
JOM encourages the online submission of materials to be considered for publication. On-line submission (with instructions) is available at https://www.editorialmanager.com/JOM/default.aspx . This is the only active peer-review system for JOM.
Those without access to online submission may submit manuscripts to the Editor. Manuscripts submitted by mail must include one hard copy and a copy on computer disk. Each mailed submission must include one full set of original figures as well as figures on diskette or CD if possible. Manuscripts submitted by mail will be uploaded to the online system in the JOM Editorial Office.
Letters to the editor should be emailed to jom@pnpco.com and not submitted through the manuscript system.
Please note: The Journal of Opioid Management is moving towards a hybrid-open access model for publishing. If you would like to have your accepted manuscript placed in open access under the Creative Commons 4.0-NC license. Please contact us for more details: radjr(at)pnpco.com or 781-899-2702 x107. Commericial reprints for manuscripts are also available. Email or call us for details.
Submission of a manuscript to JOM is taken as evidence that no portion of the text or figures has been published or submitted for publication elsewhere unless information regarding previous publication is explicitly cited and copyright permission obtained (fax or mail to JOM Editorial Office - see above) at the time of manuscript submission. Permission should be obtained for both print and online publication.
Two independent peer reviews are typically solicited. At the discretion of the Section Editor, a third review may also be solicited. The Editor is responsible for all final decisions regarding acceptance or rejection, recommendations for revision, and final editing.
Publication of material in JOM should not be interpreted as an endorsement of the material contained therein. The publisher will send galley proofs of accepted manuscripts (pdf file) to the corresponding author via email. Corrections and revisions should be returned to the publisher via email as instructed. Authors are responsible for the accuracy of references and statistical computations. The author(s) acknowledge that the publisher reserves the right to charge authors for excessive revisions made to their galley proofs. Authors are responsible for all excessive revision charges associated with their article. Publication may be withheld if authors fail to fulfill these financial obligations.
Single reprints may be purchased online at www.opioidmanagement.com, click on the Abstracts link and select year of publication to view all abstracts and purchase your selection. Reprints in quantities of 100 or more may be ordered from JOM, 470 Boston Post Road, Weston, MA 02493; Telephone: (781) 899-2702; Fax: (781) 899-4900.
All authors must sign the JOM copyright transfer form. This form will be sent to you when the article has been accepted . The signed form must be received by mail or fax at the JOM Editorial Office before an accepted manuscript can be forwarded for publication.
The corresponding author is responsible for ensuring that all individuals named as co-authors have made a major contribution to the manuscript. Authorship credit should be based on significant contributions to all of the following: 1) conception and design, or acquisition of data, or analysis and interpretation of data, 2) drafting of the manuscript or critical revision of the manuscript for important intellectual content, and 3) final approval of submitted manuscript. Each author must declare his or her contribution to the manuscript on the copyright transfer form, from the JOM Editorial Office.
Authors are required to disclose, in a cover letter accompanying their manuscript, any relevant conflict of interest, including direct or indirect financial interests they may have in the materials or subject matter dealt with in the manuscript. This information will be held in confidence by the Editor during the review process, but at the discretion of the Editor, may be included in publication of an accepted manuscript.
JOM allows research groups to be recognized in submitted manuscripts. Two options are available.
1. The names of individuals appear in the byline designated as writing for the research group (eg, Smith A, Johnson R, Williams T; for the CleftCran Research Group). The named individuals must meet the full criteria and requirements for authorship as described in the previous section. Other group members who do not qualify for authorship may be listed in an Acknowledgement.
2. Only the name of the research group appears in the byline, with an asterisk indicating that the list of authors qualifying for authorship appears at the end of the article (eg, The CleftCran Research Group*). Again, other group members who do not qualify for authorship may be listed in the Acknowledgement.
The author is responsible for ensuring the protection of a patients' anonymity. A signed consent form must accompany any figure including recognizable individuals. Shading of the eyes is not an acceptable means of rendering an individual unrecognizable. If an author chooses to use his/her own institutional patient permission form, it must include permission to use photographs for all types of publication including but not limited to print, visual, electronic, or broadcast media. Consent forms should be mailed or faxed to the JOM Editorial Office.
For manuscripts describing the results of experimental studies on humans, the authors must provide a statement in the Methods section of the manuscript that an institutional review board (IRB) approved the study and that informed consent was obtained. IRB approval letters should be submitted with with your manuscript during the online manuscript submission process to ensure timely review of your manuscript. IRB review, including exemption approval, should be completed for any manuscript that contains human or animal data, whether the data is deidentified or not. This IRB review should be completed for both prospective and retrospective patient data.
Original Articles: Reports of original clinical or basic science data pertaining to prevalence, causes, mechanisms, diagnosis, course, treatment, and prevention, including systematic reviews and meta-analysis that represent a new contribution to the field.
Clinical Reports: Case reports presenting new or novel clinical information.
Ideas and Innovations: Short communications related to novel ideas, techniques, methods of assessment, etc.
Brief Communications: Preliminary or limited results (less than 1500 words, up to 3 figures or tables) of original research pertaining to prevalence, causes, mechanisms, diagnosis, course, treatment, and prevention.
Letters to the Editor: Comments in the form of letters that express differences of opinion or supporting views of recently published JOM content.
Editorials: Brief substantiated commentaries (less than 1000 words) on subjects of interest to the JOM readership. Editorials should be narrative in form.
The American Medical Association Manual of Style is the standard reference for manuscript style. Manuscripts should be typed double-spaced with 1" margins, and left justified. Use a standard 12-point font. Pages should be numbered consecutively in the upper right hand corner. Do not print a running title. Turn off your word processing program's hyphenation feature and smart quotes feature before typing. Headings must be used to designate the major divisions of the manuscript. Up to three levels of headings may be used.
Please make sure that all identifying information has been removed from the manuscript and placed on a title page that is to be uploaded separately (however, title should also appear on the manuscript). Identifying information includes names, affiliations, and addresses of all authors as well as all acknowledgments. The title page must include:
•Title (maximum 20 words)
•Author names with degrees, in the order that they will appear in print
•Academic rank or position and institutional affiliation for each author
•Name, address, telephone number, fax number, and e-mail address of the corresponding author who will receive editorial correspondence and reprint requests
•If applicable, statement that paper was presented orally at a professional meeting, including the name, date, and location of the meeting
•Acknowledgments section, if applicable, which must also include any credits and appropriate grant numbers if the study was supported by an agency
•Running title (eight words or less)
Original articles and ideas and innovations articles should include a structured abstract of no longer than 250 words with the following headings and information, as applicable. Clinical reports should include an unstructured abstract of no longer than 100 words describing the objective, essential features and uniqueness of the case being presented, and conclusions. Structured abstracts of no longer than 150 words should be used for data-based Brief Communications articles. Non-data-based Brief Communications should include an unstructured abstract of no longer than 100 words.
Objective: State the main question or objective of the study and the major hypothesis tested, if any.
Design: Describe the design of the study indicating, as appropriate, use of randomization, blinding, criterion standards for diagnostic tests, temporal direction (retrospective or prospective), etc.
Setting: Indicate the study setting, including the level of clinical care (for example, primary or tertiary; private practice or institutional).
Patients, Participants: State selection procedures, entry criteria, and numbers of participants entering and finishing the study.
Interventions: Describe the essential features of any intervention, including the methods and duration of administration.
Main Outcome Measure(s): The primary study outcome measures should be indicated as planned before data collection began. If the hypothesis being reported was formulated during or after data collection, this fact should be clearly stated.
Results: Describe measurements that are not evident from the nature of the main results and indicate any blinding. If possible, the results should be accompanied by confidence intervals (most often the 95% interval) and the exact level of statistical significance. For comparative studies, confidence intervals should relate to the differences between groups. Absolute values should be indicated when risk changes or effect sizes are given.
Conclusions: State only those conclusions of the study that are directly supported by data, along with their clinical application (avoiding overgeneralization) and/or whether additional study is required before the information should be used in clinical settings. Equal emphasis must be given to positive and negative findings of equal scientific merit.
Key Words: A short list of the key words that reflects the article's content should follow the abstract.
(Reproduced with permission from: Haynes RB et al. More informative abstracts revisited. Ann Intern Med. 1990;113:69-76).
If a statistical analysis is conducted, explanation of the methods used must precede the Results section in the manuscript. Unusual or complex analysis methods should be referenced.
Tables should be numbered consecutively using Arabic numerals. Each table should have an appropriate title and explanation at its head. Tables may be submitted as part of the manuscript document file, with each table placed on a separate page following the references. Alternatively, tables may be submitted electronically as separate files, with one table per file, in either .doc (text) or .xls (spreadsheet) format.
All figures and illustrations must be original photographs or artwork. Figures should be numbered consecutively in the order in which they appear in the manuscript, using Arabic numerals. A list of figure legends must be included on a separate page following the body of the manuscript. The legend should explain each figure in detail.
Figures should be submitted in one of the following formats: tif, eps, jpg, pdf. Each figure should be submitted as a separate file. Composite figures made up of more than one image should be submitted as separate files (e.g. Fig 1A, Fig 1B).
Color (CMYK) or grayscale images containing only pictures (no text or thin lines) should be scanned at a resolution of 300 dpi and an image width of at least 3.25". Color (CMYK) or grayscale images containing a combination of pictures and text or thin lines should be scanned at 600 dpi and an image width or at least 3.25". Monochrome (black and white) images such as line art or line graphs should be scanned at a resolution of 1200 dpi. For symbols that must be explained, please use a key that can be shot with the figures. Do not explain them using symbols in the figure legend. Authors may be charged if artwork has to be generated to incorporate figure symbols into the figure legend.
Figures submitted at lower than the required resolutions stated above will be allowed for review purposes. However, the publication process for accepted manuscripts will be delayed until acceptable images have been submitted.
The metric system is preferred for expressing units of measure. Abbreviations may be used for terms. Write out the full term for each abbreviation at its first use in the text, unless the abbreviation is a standard unit of measure. Abbreviations used in a table must be explained in a footnote below the table. For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources.
Acknowledge all forms of financial support on the title page. All other acknowledgments should also be included in the title page.
References are organized in AMA format; that is, they are to be cited numerically in the text and in consecutive order, including the first three authors followed by et al., and listed at the end of the article in the following format:
Journal articles— 1. Mudd P, Smith JG, Allen AZ, et al.: High ideals and hard cases: The evolution of opioid therapy for cancer pain. Hastings Cent Rep. 1982; 12(2):11-14.
Books— 1. Bayles SP (ed.): Nutritional Supplements and Interactions with Analgesics. Boston: GK Hall & Co., 1978.
Book chapters— 1. Martin RJ, Post SG: Introducing alternative prescribing strategies. In Smith J, Howard RP, and Donaldson P (eds.): The Oncology Management Handbook. Madison, WI: Clearwater Press, 1998, pp. 310-334.
Web sites— Health Care Financing Administration: HCFA Statistics at a glance. Available at: www.hcfa/gov/stats/stahili.htm. Accessed December 27, 2002.
USER ALERT
New for 2020
We have rolled out a new peer-review system for Journal of Opioid Management.
That new peer-review system is located at: https://www.editorialmanager.com/JOM/default.aspx
NEW MANUSCRIPTS submitted after 1/1/2020
All new manuscripts should be submitted via the link above. Please note that we transferred all user details from our old system but this would be a great time to verify your user details including email address, mailing address, ORCHID, etc. Addtionally, please update your "Classifications" in your system account. In the past, these were called KEYWORDS and were used to denote your expertise and/or specialities in practice.
EXISTING MANUSCRIPTS - Submitted before 12/31/2019
If you have submitted a manuscript before 12/31/2019, please use the links in your emails from that system to access the old peer-review system. That system will stay active until all manuscripts have processed through the peer-review process.
The direct link to that system is http://jom.allentrack2.net if you need to access your manuscript submitted before 12/31.2019.
If you have any questions, please contact our offices at 781-899-2702 ext 114 or reach out to our editorial offices via email at jom(at)pnpco.com.
To submit a manuscript, please go to https://www.editorialmanager.com/JOM/default.aspx . Click on "New users should register for a new account". After you register you will be able to click on a link to submit a manuscript, this will forward you to a page with instructions.
Login to access subscriber-only resources.
